Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, Fagan AM, Holtzman DM, Mintun MA. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch Neurol. 2009 Dec;66(12):1469-75. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. All these observations of amyloid deposition in prodromal AD clearly demonstrate that amyloidosis is an early marker of a pathological process that will lead to AD dementia. Accordingly, they also demonstrate that preamyloid, oligomer deposition has not this huge toxicity that makes hot headlines.

    View all comments by Andre Delacourte

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Multi-Paper Alert: More Data That Brain Amyloid Is Bad for You
  2. St. Louis: Biomarkers Pre-dementia—Like eFAD, Like LOAD?
  3. Anti-Amyloid Treatment in Asymptomatic AD Trial